EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluating the Cytotoxic and Apoptotic Potential of Terpinen-4-OLAgainst SF767 Glioblastoma Cells Via P53 Modulation: An In-Vitro Study

Neelam Bilal, Shazia Ramzan, Kanwar Sajjad Ali, Hina Sadaf, Zoja Muzaffar, Sehar Shamshad Ali, Zoraiz Chaudhry, Tahir Maqbool

JAIMC: Journal of Allama Iqbal Medical College · 2025

DOI: 10.59058/4vq08w26 ↗
AbstractBibliografische Angaben

Abstract

Background and Objectives: Terpinen-4-ol (T4-ol) is a monoterpene derivative of essential oil which hasmany anti- inflammatory, bactericidal and antifungal activities and is safe as compared to other treatmentoptions available. Our study's objectives were to analyze the effects of different concentrations of Terpinen4-ol on apoptosis of cell lines.Methods: This in vitro experimental study was conducted at the IMBB Department, University of Lahore,Lahore Pakistan, from October 2022 to March 2023. Study treatment was divided into four groups: negativecontrol (normal cell line), positive control (cisplatin) Terpinen-4-ol (experimental group) and vehicle control(DMSO). In order to culture cells cryovials were thawed and then cells were cultured in T75 flasks. To assessthe cell viability MTT assay was used. Bioassay technology laboratory ELISA kit was used to evaluateinflammation and apoptosis. Graph Pad prism was used to perform statistical analysis. The data wasanalyzed using one- way analysis of variance (ANOVA) with bonferroni comparison within groups. P ≤ 0.05was considered statistically significant.Results: When compared to the control group, the treated lines showed more apoptotic changes. P-value was≤ 0.05.Conclusion: In this study we have observed anticancer effects of T4-ol against GBM cell line by observingp53 induced apoptosis.Key Words: Terpinen-4-ol (T-4-ol), Glioblastoma (GBM), apoptosis, MTTand Crystal Voilet assay.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →